China's drug price reforms: Much of the same?

The new pharmaceutical pricing reforms leave many controls in place, sparking questions on the objective of the changes. Here we push past the fog to see what's really going on

11 minute readJune 12, 2015 at 04:43 AM

clpstaff

A series of pricing reforms have taken place in China's pharmaceutical sector. On May 6, the National Development and Reform Commission (NDRC) and six other departments issued the

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)